Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

By J. Williamson, M. Supiano, W. Applegate, D. Berlowitz, R. Campbell, Glenn M. Chertow, Lawrence J. Fine, William E. Haley, Amret T Hawfield, Joachim H. Ix and 15 more. Journal of the American Medical Association (JAMA), 2016

1,186 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/ed320280bd1682dddb22463d3e629f2056b32b71

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Rhian M. Touyz
2. P. Whelton
3. Massimo F. Piepoli
4. Stephen Burgess
5. S. Thompson

Citations in the corpus

• 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (2024, positive): “421 Therefore, given the totality of evidence from clinical trials, 293,415–417 very old and very frail patients with hypertension should not be denied the benefits of BP-lowering treatment.”
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018, neutral): “, 2016 (190) 27195814 Aim: Intensive SBP goal <120 mm Hg) vs.”
• Global vascular guidelines on the management of chronic limb-threatening ischemia (2019, background): “14 years.(315) The study documented a significantly lower incidence of composite cardiovascular events of death with intensive control.”